Chitosan Oligosaccharides Market

Chitosan Oligosaccharides Market Size, Market Forecast and Outlook By FMI

The Chitosan Oligosaccharides market was valued at USD 3.52 billion in 2025, projected to reach USD 3.99 billion in 2026, and is forecast to expand to USD 14.02 billion by 2036 at a 13.4% CAGR. Chitosan oligosaccharides, low-molecular-weight deacetylation derivatives of chitin, are attracting concentrated investment from pharmaceutical, agricultural, and cosmetic sectors as peer-reviewed evidence for their antimicrobial, immunomodulatory, and plant-defence properties accumulates. What was previously a niche academic research material has transitioned into a commercially specified ingredient in pharmaceutical formulation, crop protection, and functional food systems across multiple regulated markets.

Absolute dollar growth of USD 10.03 billion across the forecast period positions Chitosan Oligosaccharides among the fastest-growing functional biopolymer ingredient categories globally. FMI analysts observe that the marine chitin sourcing model, which has historically dominated production, faces structural competition from insect-derived chitin, which holds 22.7% of source segment demand in 2026. Regulatory acceptance of insect-derived chitin inputs in European Union markets under the Novel Food Regulation framework is expected to accelerate the transition, with implications for supply geography and feedstock pricing that buyers should factor into long-range procurement models.

Summary of Chitosan Oligosaccharides Market

• Chitosan Oligosaccharides Market Definition
  • The Chitosan Oligosaccharides market covers low-molecular-weight chitin deacetylation derivatives used across pharmaceutical, agricultural, cosmetic, and food manufacturing applications, sourced from marine, insect, and fungal feedstocks.
• Demand Drivers in the Market
  • Peer-reviewed evidence for chitosan oligosaccharide antimicrobial and immunomodulatory bioactivity is expanding pharmaceutical formulation interest across European and Asian regulated markets.
  • EU regulatory acceptance of insect-derived chitin inputs opens new feedstock channels, reducing supply concentration risk relative to the historically marine-dominated production base.
  • Agricultural sector adoption of chitosan oligosaccharide-based biostimulants in high-value horticulture, particularly in India and China, generates volume demand as growers seek crop protection solutions compatible with organic certification standards.
• Key Segments Analyzed in the FMI Report
  • Powder Form holds 44.0% of Form demand in 2026, driven by handling, stability, and formulation compatibility advantages across pharmaceutical manufacturing and agricultural input preparation environments.
  • Pharmaceutical Companies account for 28.0% of End User demand in 2026, reflecting the highest-value application segment where purity specifications and regulatory documentation requirements create defensible supplier positioning.
  • China records the fastest country-level growth at 12.3% CAGR through 2036, combining established marine chitosan production infrastructure with rapidly expanding domestic biostimulant and functional food application markets.
• Analyst Opinion at FMI
  • Nandini Roy Choudhury, Principal Consultant for Food & Beverage is of the opinion that the Chitosan Oligosaccharides market's structural growth driver is not a single application but a convergence of regulatory acceptance events across pharmaceutical, food, and agricultural segments occurring in near-simultaneous timeframes in multiple major markets. Producers that achieve multi-grade certification from a single production platform will capture margin across all three segments simultaneously, compressing the cost disadvantage that currently limits smaller producers to single-segment positioning.
• Strategic Implications / Executive Takeaways
  • Chitosan oligosaccharide producers targeting European pharmaceutical supply chains should pursue European Pharmacopoeia monograph compliance as a prerequisite for inclusion on approved supplier lists at German, Swiss, and French pharmaceutical manufacturers.
  • Agricultural input formulators should invest in biostimulant registration infrastructure in India and Brazil, where regulatory pathways for biopolymer-based crop protection products are advancing faster than comparable North American approval processes.
  • Cosmetic ingredient buyers should require third-party molecular weight characterisation documentation from suppliers to differentiate compliant chitosan oligosaccharides from high-molecular-weight chitosan blends that do not meet dermal penetration and bioactivity specifications.

As per FMI, China leads regional growth at a 12.3% CAGR through 2036, combining established chitosan production infrastructure with expanding domestic applications in agricultural biostimulants and functional food sectors. India follows at 11.2%, driven by pharmaceutical sector demand for antimicrobial ingredients and crop protection applications in high-value horticulture. Germany records 10.1% CAGR, anchored by pharmaceutical manufacturing demand and cosmetic formulation specifications. The United Kingdom advances at 9.0%, supported by functional food formulation and pharmaceutical compounding demand. The United States registers 8.2% CAGR, with growth concentrated in pharmaceutical applications and emerging crop bioprotection uses.

Chitosan Oligosaccharides Market Definition

The Chitosan Oligosaccharides market encompasses the commercial production, purification, and distribution of low-molecular-weight oligomers derived from chitin deacetylation across marine, insect, and fungal feedstock sources. Applications include pharmaceutical active ingredient formulation, agricultural biostimulant and biopesticide products, cosmetic skin-care ingredient supply, functional food and beverage fortification, and industrial water treatment processes.

Chitosan Oligosaccharides Market Inclusions

Market scope covers global and regional revenue estimates for chitosan oligosaccharides in all commercially available forms, grades, and end-user applications. The forecast window spans 2026 to 2036, with country-level CAGR analysis and source-type breakdown. Pricing differentials between pharmaceutical, cosmetic, food, and industrial grades are addressed as analytical dimensions.

Chitosan Oligosaccharides Market Exclusions

High-molecular-weight chitosan polymers not meeting the oligosaccharide molecular weight definition are excluded from market sizing. Raw chitin before deacetylation processing, native crustacean shell waste, and chitin nanofibers engineered for structural composite applications fall outside the defined scope. Finished pharmaceutical drug products incorporating chitosan oligosaccharides as an excipient are not included.

Chitosan Oligosaccharides Market Research Methodology

• Primary Research: Primary Research: FMI analysts conducted interviews with chitosan oligosaccharide producers in China and Japan, pharmaceutical formulation scientists in Germany and the United Kingdom, and agricultural input procurement managers in India and the United States.
• Desk Research: Desk Research: European Food Safety Authority novel food applications, EU Novel Food Regulation (2015/2283) filings for insect-derived chitin, US EPA biopesticide registration data, and ISO biocompatibility testing standards were reviewed.
• Market-Sizing and Forecasting: Market-Sizing and Forecasting: A bottom-up approach aggregates production capacity by feedstock source type and grade, weighted against end-use application demand forecasts by region.
• Data Validation and Update Cycle: Data Validation and Update Cycle: Projections were cross-validated against pharmaceutical ingredient market volume data from national pharmacopoeia authorities and agricultural biostimulant sales data from industry registries.

Chitosan Oligosaccharides Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 3.99 Billion
Industry Value (2036)	USD 14.02 Billion
CAGR (2026-2036)	13.4%
Source	Future Market Insights, 2026

Source: FMI analysis based on primary research and proprietary forecasting model

Key Industry Highlights

Evolution in Biotechnology

Advancements in biotechnology are making it possible to make synthetic chitin and chitosan oligosaccharides (COS) in innovative ways. Which means more COS can be produced, further it will be available more for various uses.

With these innovations, companies can explore different applications for COS in food, medicine, and cosmetics. As a result, the market for chitosan oligosaccharides is likely to grow, as more products can include these ingredients, meeting the needs of different industries and consumers.

MycoTechnology uses fermentation to produce various ingredients, including chitosan, from fungi. They are planning to create sustainable and innovative food solutions.

Growing Use of COS, in Beauty Industry

The beauty and skincare industry is moving towards using more natural and organic ingredients in products. Chitosan oligosaccharides (COS) as an ingredient are gaining popularity because they help in moisturizing the skin and promotes healing.

As consumers are looking for safer and healthier options, many skincare brands are adding COS to their products. This is boosting sales in the beauty and skincare industry, as more individuals want effective skincare solutions that are made from natural ingredients, further leading to the growing demand for COS in cosmetics.

MediDerm specializes in dermatological products, which also use chitosan in its formulations to enhance skin health.

Companies Preferring to go with Sustainable Sourcing

As more individuals and companies focus on being environmentally friendly, the demand for chitosan made from renewable sources is rising. Chitosan can be sourced from shrimp shells and insects, which are sustainable sources. This attracts consumers who want to support eco-friendly products and practices. Due to this interest in sustainability, many industries, including food, cosmetics, and agriculture, are increasingly using chitosan.

Use of COS in Animal Feed for Better Health

COS is being added to animal feed as they boost growth and strengthen the immune system of livestock. This means animals can grow better and stay healthier, which is important for farmers. Due to which, the demand for COS in animal feed is increasing, further leading to higher sales in the animal feed market as more farmers are adopting these innovations.

Kemin Industries offers a range of animal feed additives that include COS which enhances animal health, growth, and immune function.

2021 to 2024 Global Chitosan Oligosaccharides Sales Analysis Compared to Demand Forecasts for 2026 to 2036

Global Chitosan Oligosaccharides sales increased at a CAGR of 10.7% from 2021 to 2025. For the next ten years (2026 to 2036), projections are that expenditure on Chitosan Oligosaccharides will rise at 13.4% CAGR

Regulatory support for natural ingredients is increasing in many industries, including food, pharmaceuticals, and cosmetics. Governments and organizations are acknowledging the benefits of using safe, natural substances like chitosan oligosaccharides (COS).

This support motivates manufacturers to include COS in their products as they meet safety and quality standards. Due to this more companies are willing to use COS in their formulations, knowing they meet up with regulations. This is driving sales across various industries, as consumers prefer products made with natural ingredients.

In the United States, FDA has recognized chitosan as Generally Recognized As Safe (GRAS) for use in food products, which supports its inclusion in various food and dietary supplement formulations.

There is a rising interest in functional foods, which provide health benefits beyond basic nutrition. Individuals are looking for products that can help improve their health, such as supporting digestion and supporting weight management.

Chitosan oligosaccharides (COS) are being used in food-grade dietary supplements and health products because they are known to help with these issues. As more consumers seek out foods that can enhance their well-being, manufacturers are gradually including COS in their products.

Market Concentration

Tier 1 companies comprise market leaders with market revenue of above USD 40 million securing significant sales domain share of 40% to 50% in the global sphere. These business leaders are known for high production capacity and a wide product offering.

These trade leaders are distinguished by their extensive expertise in manufacturing and reforming across multiple packaging formats and a broad geographical reach, supported by a robust consumer base. They provide a wide range of series including reconditioning, recycling, and manufacturing utilizing the latest technology and meeting the regulatory standards providing the highest quality.

Prominent companies within tier 1 include ChitoLytic, Alpha Chitin, HuminRich, Dora Agri, BZ Oligo Biotech Co., Ltd, TCI America, VWR International, and Qingdao Yunzhou Biochemistry Co., Ltd.

Tier 2 companies include mid-size players with revenue of USD 10 to 40 million having presence in specific regions and highly influencing the local retail space. These are characterized by a strong presence overseas and strong consumer base knowledge.

These industry players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include Heppe Medical Chitosan GmbH, Golden-Shell Pharmaceutical Co., Ltd, Qingdao BZ Oligo Biotech Co., Ltd, Yaizu Suisankagaku Industry Co., Ltd, Bioline Corporation, and Kunpoong Bio Co., Ltd.

Tier 3 includes the majority of small-scale companies operating at the local presence and serving niche demand space having revenue below USD 10 million. These companies are notably oriented towards fulfilling local marketplace demands and are consequently classified within the tier 3 share segment.

They are small-scale players and have limited geographical reach. Tier 3, within this context, is recognized as an unorganized field, denoting a sector characterized by a lack of extensive structure and formalization when compared to organized competitors.

Country-wise Insights

The following table shows the estimated growth rates of the top sales domains. India and China are set to exhibit high chitosan oligosaccharides consumption, recording CAGRs of 11.2% and 12.3%, respectively, through 2036.

Countries	CAGR 2026 to 2036
United States	8.2%
United Kingdom	9.0%
Germany	10.1%
India	11.2%
China	12.3%

Source: FMI analysis based on primary research and proprietary forecasting model

United States to Retain Dominance in Chitosan Oligosaccharides Sales

The ecosystem for Chitosan Oligosaccharides in the United States is projected to exhibit a CAGR of 8.2% during the assessment period. By 2036, revenue from the sales of Chitosan Oligosaccharides in the country is expected to reach USD 607.5 million.

As more individuals want to improve their health simply by what they are consuming. Chitosan oligosaccharides (COS) are being added to these products as they are known to help with gut health and offer other benefits, which makes them popular among health-conscious consumers.

Moreover, the FDA has approved chitosan as Generally Recognized As Safe (GRAS). Which means that it is considered safe for use in food and supplements. This encourages manufacturers to include COS in their products, leading to increased demand in the market for functional foods and dietary supplements.

Demand Outlook for Chitosan Oligosaccharides in Germany

Chitosan Oligosaccharides demand in Germany is calculated to rise at a value CAGR of 10.1% during the forecast period (2026 to 2036). By 2036, Germany is expected to account for 19.5% of Chitosan Oligosaccharides sales in Europe.

Germany has a growing nutraceutical domain, where individuals are looking for products that blend nutrition with health benefits. Chitosan oligosaccharides (COS) fit well into this as they offer various health benefits, such as improving digestion and supporting weight management.

Moreover, Germany is home to many research institutions and universities that research about food science and nutrition. These institutions often conduct ongoing research on COS, further exploring their benefits and uses. This research helps create new and innovative products, increasing interest and demand for COS in the nutraceutical market.

Category-Wise Insights

Insect Sources- A Sustainable and Nutritious Choice

Segment	Insect Sources (Sources)
Value Share (2026)	22.7%

There is an increasing curiosity in alternative protein sources as individuals are becoming more aware of the environmental problems caused by traditional animal farming. Insects are seen as a sustainable option because they require much less land, water, and food to raise compared to cows or pigs. This makes them a preferred choice for those looking to reduce their environmental impact.

In addition to being sustainable, insects are also rich in protein and other important nutrients. The chitosan derived from insects can provide health benefits similar to those from chitosan sourced from shrimp or crabs. This makes insect-based COS appealing for use in functional foods and dietary supplements, as they can help in improving health while also being environmentally friendly.

The Growing Role of COS in Water Treatment

Segment	Industrial Grade (Grade)
Value Share (2026)	21.3%

Chitosan oligosaccharides (COS) are gaining popularity in water treatment as they can effectively remove contaminants and improve water quality. Various industries are looking for more efficient and eco-friendly ways to manage wastewater, and COS provides a natural solution to this problem.

In agriculture, COS are also known as natural biopesticides. They help in protecting plants from pests and diseases without the harmful effects of synthetic chemicals. Which makes them appealing to farmers who practice organic and sustainable farming. By using COS, farmers can keep their crops healthy while being careful for environment, which is increasingly important to consumers.

Competition Outlook

Market players are focusing on investing in R&D to develop functional ingredients with enhanced health benefits and sensory properties. They are diversifying product portfolios to meet diverse consumer needs and forming strategic partnerships with firms, to leverage expertise and accelerate innovation.

These strategies help them stay competitive in the evolving chitosan oligosaccharides market. Further, many companies are adopting sustainable practices in sourcing and production.

For instance

• NutraGreen Biotechnology company produces chitosan oligosaccharides derived from various sources, including fungi and shrimp. They focus on applications in health supplements, food, and agriculture.

Leading Chitosan Oligosaccharides Brands

• ChitoLytic
• Alpha Chitin
• HuminRich
• Dora Agri
• BZ Oligo Biotech Co., Ltd
• TCI America
• VWR International
• Qingdao Yunzhou Biochemistry Co., Ltd
• Heppe Medical Chitosan GmbH
• Golden-Shell Pharmaceutical Co., Ltd
• Qingdao BZ Oligo Biotech Co., Ltd
• Yaizu Suisankagaku Industry Co., Ltd
• Bioline Corporation
• Kunpoong Bio Co., Ltd
• Others

Scope of the Report

Metric	Value
Quantitative Units	USD 3.99 Billion to USD 14.02 Billion, at a CAGR of 13.4%
Market Definition	Low-molecular-weight chitin deacetylation derivatives across marine, insect, and fungal feedstocks serving pharmaceutical, agricultural, cosmetic, and food applications.
Source Segmentation	Insect Sources, Marine Sources, Fungal Sources, Other Sources
Grade Segmentation	Industrial Grade, Pharmaceutical Grade, Cosmetic Grade, Food Grade
End User Segmentation	Pharmaceutical Companies, Food and Beverage Manufacturers, Cosmetic and Personal Care Brands, Agricultural Companies, Water Treatment Firms, Animal Feed Manufacturers
Form Segmentation	Powder, Liquid, Gel, Granules
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	United States, United Kingdom, Germany, India, China, and 40 plus countries
Key Companies Profiled	ChitoLytic, Alpha Chitin, HuminRich, Dora Agri, BZ Oligo Biotech Co. Ltd, TCI America, VWR International, Qingdao Yunzhou Biochemistry Co. Ltd, Heppe Medical Chitosan GmbH, Golden-Shell Pharmaceutical Co. Ltd
Forecast Period	2026 to 2036
Approach	Bottom-up aggregation of production capacity by feedstock source and grade, cross-validated against end-use application demand forecasts by region

Key Segments of the Report

By Source:

This segment is further categorized into marine sources (shrimp, crab, lobster), insect sources:(beetles, other arthropods), fungal sources, and other sources (squid pen, synthetic chitin (derived from biotechnological processes)

By Grade:

This segment is further categorized into Food Grade, Pharmaceutical Grade, Cosmetic Grade, and Industrial Grade.

By End User:

As end user, the ecosystem has been categorized into pharmaceutical companies, food and beverage manufacturers, cosmetic and personal care brands, agricultural companies, water treatment and environmental firms, and animal feed manufacturers.

By Form:

This segment is further categorized into powder, liquid, gel, and granules.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Eastern Europe, Western Europe, East Asia, South Asia & Pacific, Central Asia, Balkan and Baltic Countries, Russia & Belarus and the Middle East & Africa.

Bibliography

• 1. European Food Safety Authority. (2024). Novel Food Application Assessment: Chitin-Glucan from Aspergillus Niger. EFSA Journal.
• 2. European Commission. (2024). Regulation (EU) 2015/2283 on Novel Foods: Updated Authorisation Register. European Commission.
• 3. United States Environmental Protection Agency. (2024). Biopesticide Registration: Chitosan Oligosaccharides Active Ingredient. US EPA Office of Pesticide Programs.
• 4. Food and Agriculture Organization of the United Nations. (2024). Chitin and Chitosan: Sources, Production, Physicochemical Properties and Applications. FAO.
• 5. International Organization for Standardization. (2023). ISO 10993-5: Biological Evaluation of Medical Devices - Tests for In Vitro Cytotoxicity. ISO.

This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.